Podcasts about Chronic kidney disease

Did you know that people who have received a kidney transplant are at a much higher risk for skin cancer? We sat down with experts to discuss how you can lower your risk. In this episode we heard from: Dr. Cerrene Giordano is a dermatologist and Mohs Micrographic surgeon at Roswell Park Comprehensive Cancer Center in Buffalo, New York. She specializes in treating skin cancers, particularly in patients who are high risk such as those who have received organ transplants, have weakened immune systems, or a genetic predisposition to skin cancer development. Her expertise includes skin cancer surgery, wound reconstruction, and the management of skin cancers such as melanoma, basal cell carcinoma, and squamous cell carcinoma, to name a few. Dr. Giordano is also involved in research aimed at improving pain management following dermatologic surgeries and exploring advanced imaging techniques to enhance surgical outcomes. Kent Bressler is a retired RN who was diagnosed with FSGS in 1984, and received a living donor transplant from his brother Kip in 1987. Kent is an active advocate for preemptive kidney transplant and has on the recommendation of NKF worked closely with the DoD and PCORI as a consumer peer reviewer. He is an NKF peer mentor and advocate who has collaborated on an editorial “Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of Chronic Kidney Disease,” published in AJKD in 2019. He will also be participating in the development of the new NKF Patient Network serving on the Data Input and Integration Committee. He has been an active hill advocate for the NKF for six years and was the proud recipient of the 2017 Richard K. Salick Advocacy Award. Kent is also an Army Veteran and retired from the Veterans administration as an RN. He is the co-founder of Kidney Solutions a not for profit program in Texas that assists patients and families in the transplant process and in finding a donor. He is currently an assistant team leader for Region 7. Kent and Cathy Bressler have been married for 56 years and their family consists of Gretchen and Todd Rossington and their son Colt and Celeste and Alex Brown and their children John Banks, Catherine and Alexis Brown. Risa Simon is a passionate author, speaker, mentor, kidney patient coach and advocate. As the founder and CEO of The Proactive Path and the TransplantFirst Academy, her mission is to help all kidney disease patients advocate for their best life possible—the life she now lives. As a preemptive kidney transplant recipient, Risa was able to circumvent the need for dialysis. This is her hope for all eligible kidney patients. Risa gives back a good portion of her time by serving on various advisory committees, such as the National Kidney Foundation's (NKF's) Kidney Action committee, the American Association of Kidney Patients (AAKP) program and convention committees and she chairs the Phoenix Chapter's Polycystic Kidney Disease (PKD) education committee.  She is also a member of the PKD Legacy Society and serves as a Peer Mentor for the National Kidney Foundation (NKF). Risa's message is all about empowering kidney patients to bring their voice to life.    Additional Resources: Dr. Cerrene Giordano Protect the Skin You're In Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.  

Kent Bressler talks with Josie Maier, co-director of Project Donor—a nonprofit offering free support to living organ donor candidates. Kent reflects on his journey as a living donor kidney transplant recipient and his recent triumph over cancer. Josie sheds light on key challenges in organ donation, especially how BMI restrictions can prevent otherwise willing individuals from donating. Project Donor works to shift the conversation by helping potential donors overcome reversible barriers through free weight loss programs, smoking cessation resources, and therapy. Together, Kent and Josie highlight the urgent need for more living kidney donors and the importance of awareness. Listen in and discover how you can make a difference in this life-saving mission. For more information about Project Donor, visit projectdonor.org and to connect with Kidney Solutions, go to kidneysolutions.org. Host: Kent Bressler Producer: Jason Nunez Remember to keep breathing, and don't miss the next amazing episodes of Kent's Kidney Stories!  

Join us for an inspiring episode of the Diary of a Kidney Warrior Podcast as we sit down with Ravi—a fellow Kidney Warrior whose story is one of courage, connection, and unshakeable will. From his unexpected diagnosis of Chronic Kidney Disease (CKD) to life on dialysis, Ravi opens up about the challenges and triumphs that have shaped his journey.   What began as a routine post-holiday health concern quickly became a life-altering revelation. Ravi walks us through the early warning signs, the shock of diagnosis, and the complexities of seeking care amid a global pandemic. As dialysis buddies turned friends, Ravi and our host share a powerful camaraderie that highlights the strength found in community.   In this candid conversation, Ravi speaks openly about the physical, mental, and emotional toll of CKD—detailing side effects, collapsing from poor health, and the resilience needed to push through. Balancing a demanding career in IT, he reveals how he copes with the daily realities of dialysis and the hope of an eventual transplant.   Whether you're newly diagnosed or supporting someone with CKD, Ravi's insights offer encouragement, practical advice, and heartfelt wisdom. He champions the importance of early detection, mental well-being, and finding purpose amidst the struggle.  

In this podcast, Dr. Rahul Jain and Dr. Sheldon Tobe join Sara and Gail to discuss the 2025 updates to the Chronic Kidney Disease and Diabetes from the Diabetes Canada Clinical Practice Guidelines.

Dr. Thomas Weims, Professor at UC Santa Barbara, shares his revolutionary findings on treating polycystic kidney disease through ketogenic interventions. After 25 years of research, his lab accidentally discovered that ketosis dramatically halts and even reverses PKD progression—something previously thought impossible. The medical establishment had long maintained that PKD, a genetic disease affecting 600,000 Americans, was untreatable through dietary means. Yet Weims' research demonstrates that beta-hydroxybutyrate (BHB), the primary ketone produced during ketosis, shows more potent effects than any pharmacological intervention his team tested. In a groundbreaking clinical trial, patients on a ketogenic diet experienced improved kidney function and reduced kidney volume in just three months—the first time such reversal has ever been documented in PKD. Weims explains the science behind this therapeutic approach, how it challenges entrenched medical dogma, and why this metabolic therapy may benefit all forms of chronic kidney disease. This conversation exposes how decades of medical education about diet and kidney health have been based on hypothetical papers rather than clinical evidence, offering hope to millions suffering from progressive kidney conditions.BIG IDEA"What we found more recently is that the progression of polycystic kidney disease is not really driven by gene mutations as previously thought—a patient inherits a bad gene, but that doesn't necessarily mean they will have rapidly progressing PKD."Gary Taubes Contact InfoWebsite: https://uncertaintyprinciples.substack.com/Website: https://garytaubes.com/Send Dr. Ovadia a Text Message. (If you want a response, include your contact information.) Dr. Ovadia can not respond here. To contact his team please email team@ifixhearts.com If you like what you hear, I wanna make it easier for you to take action on your health.Head over to i fix hearts.com/book to grab a copy of my book, Stay Off My Operating Table, and if you're ready to go deeper or talk to someone from my team, just go to i fix hearts.com/talk. Stay Off My Operating Table on X: Dr. Ovadia: @iFixHearts Jack Heald: @JackHeald5 Learn more: Stay Off My Operating Table on Amazon Take Dr. Ovadia's metabolic health quiz: iFixHearts Dr. Ovadia's website: Ovadia Heart Health Jack Heald's website: CultYourBrand.com Theme Song : Rage AgainstWritten & Performed by Logan Gritton & Colin Gailey(c) 2016 Mercury Retro RecordingsAny use of this intellectual property for text and data mining or computational analysis including as training material for artificial intelligence systems is strictly prohibited without express written consent from Dr. Philip Ovadia.

In the first of a two-episode series on chronic kidney disease (CKD), Dr Hannah Rosa is joined by Dr Will Hinchliffe, a Consultant in Renal and General Medicine working in the North East and North Cumbria. They discuss which people are at risk of CKD, how to test for it and diagnose it and, lastly, which patients require a referral to secondary care. This episode is mostly based on the NICE guideline on assessment and management of CKD and aims to help you to improve the lives of your patients by diagnosing CKD earlier and referring those who may benefit from specialist input sooner.Access episode show notes containing key references and take-home points at:https://gpnotebook.com/en-GB/podcasts/renal-medicine/ep-163-chronic-kidney-disease-among-adults-in-primary-care-testing-diagnosis-and-referral.Did you know? With GPnotebook Pro, you can earn CPD credits by tracking the podcast episodes you listen to. Learn more.

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. Welcome to diabetes core update where every month we go over the most important articles to come out in the field of diabetes. Articles that are important for practicing clinicians to understand to stay up with the rapid changes in the field.  This issue will review: 1.    Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes 2.    Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension Meta-Analysis 3.    The Diabetes Prevention Program and Its Outcomes Study: NIDDK's Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact 4.    Comparative effectiveness of alternative second‐line oral glucose‐lowering therapies for type 2 diabetes: a precision medicine approach applied to routine data 5.    Phase 3 Trial of Semaglutide in Metabolic Dysfunction– Associated Steatohepatitis   For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

Send us a textWelcome back Rounds Table Listeners! Today we have the next episode in our Clinical Practice Guidelines series. Drs. Mike and John Fralick discuss the top takeaways from the 2024 KDIGO Clinical Practice Guidelines for chronic kidney disease. Here we go!1. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (0:00 - 24:24)Access the KDIGO 2024 "Top 10 Takeaways" PDFs here: https://kdigo.org/guidelines/ckd-evaluation-and-management/The Good Stuff:Nephrology Trial Files - https://nephrotrialfiles.substack.com/ (24:25 - 24:48)The Phoenician Scheme (24:49 - 25:33)Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePods

Send us a textThis recording features audio versions of Month Year Journal of Vascular and Interventional Radiology (JVIR) abstracts:Optimal Timing of Percutaneous Cholecystostomy across Different Grades of Acute Cholecystitis: A Retrospective Cohort Study ReadGallbladder Cryoablation for Calculous Cholecystitis Initially Treated with Percutaneous Drainage: A Prospective Trial in High-Risk Patients ReadComparative Prognostic Utility of Updated Model for End-Stage Liver Disease Scores for Prediction of Early Mortality after Transjugular Intrahepatic Portosystemic Shunt Creation ReadLong-Term Outcomes of Angioplasty and Stent Placement for Portomesenteric Vein Obstruction following Hepatobiliary and Pancreatic Surgery ReadThe Impact of Chronic Kidney Disease on Amputation and Death Rates in Patients with Peripheral Artery Disease in the United States ReadPercutaneous Microwave Ablation of Small (

Kent Bressler welcomes Glenna Frey, MSN, APRN-CNS. She has dedicated over 40 years to nephrology nursing, specializing in hemodialysis, peritoneal dialysis, and kidney transplantation. In 2017, she donated a kidney to a stranger at the Cleveland Clinic. The following year, she co-founded Kidney Donor Conversations (KDC), a nonprofit providing education and support for living kidney donation with her daughter, Amanda. Glenna serves as executive director of KDC and frequently presents programs on living kidney donation. She is a member of the American Nephrology Nurses Association and the National Kidney Donation Organization. She volunteers with the National Kidney Foundation and other kidney-focused groups. Her connection to kidney disease and transplantation is deeply personal. Many of her relatives, including her husband Bob, have Polycystic Kidney Disease (PKD). Bob has undergone dialysis and is now living with his second kidney transplant from a living donor. Her children, Amanda and Sawyer, also have PKD but currently maintain normal kidney function. Glenna is a published author and contributor to several works on kidney donation and nephrology nursing, including In Pursuit of a Better Life: The Ultimate Guide for Finding Living Kidney Donors, Thriving Post Kidney Transplant, and the Nephrology Nursing Journal. Additionally, she served as a reviewer for the 4th edition of Contemporary Nephrology Nursing. She is the author of the book Understanding Living Kidney Donation: The Best Treatment for Kidney Disease, now available on Amazon. Glenna also specializes in holistic therapies, holds a Black Belt in Tae Kwon Do, and is a Hula Hoop instructor. She resides in Northwest Ohio with her husband and enjoys time with her cat, chocolate lab, as well as crocheting, and native plant gardening. Glenna's pride and joy are her children, Amanda and Sawyer, and her granddaughter, Zora. For inquiries, contact: https://www.linkedin.com/in/glennafreyrnkidneydonor/ or visit https://www.facebook.com/LivingKidneyDonationBook For more information on Kidney Solutions and to join our supportive community, visit kidneysolutions.org Host: Kent Bressler Producer: Jason Nunez Remember to keep breathing, and don't miss the next amazing episodes of Kent's Kidney Stories!  

Send us a textWelcome back Rounds Table Listeners! Today we have another special episode— Trial Files turns two years old this June, and we're celebrating with an episode summarizing the Top 5 RCTs in the Trial Files catalogue to date. Dr. Mike Fralick takes us through five trials in 15 minutes. Here we go!1. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (0:00 - 3:08)2. Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia (3:09 - 5:37)3. Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (5:38 - 8:33)4. Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections (8:34 - 11:22)5. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (11:23 - 13:23)Happy 2nd Birthday, Trial Files!A free monthly newsletter on practice-changing trials, delivered straight to your inbox-- sign up at https://trialfiles.substack.com/ (13:24 - 14:19)Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePods

Alice Sheridan, MD, FASN, and Martina McGrath, MD, FASN, speak with guest editors Dr. Reaves and Dr. Sarnak on "Benefits and risks of intensive blood pressure control in CKD patients: what does the current evidence tell us?" from nephSAP Vol 24, No 2.

Alice Sheridan, MD, FASN, and Martina McGrath, MD, FASN, speak with guest editors Dr. Reaves and Dr. Sarnak on "Benefits and risks of intensive blood pressure control in CKD patients: what does the current evidence tell us?" from nephSAP Vol 24, No 2.

In this podcast, Dr. Wendy St. Peter and Dr. Katie Cardone discuss the AJHP theme issue on the management of chronic kidney disease with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this powerful and deeply personal episode of Diary of a Kidney Warrior Podcast, we meet Christy—an extraordinary kidney warrior whose story of resilience will inspire anyone facing life's toughest battles.   Christy takes us back to 2006, when a life-threatening crisis landed her in a coma, leading to kidney failure caused by septicaemia and peritonitis. What followed was nearly two decades of living with chronic kidney disease (CKD)—a journey marked by dialysis as a young adult, the heartbreak of a failed transplant, and the constant balancing act of managing additional health complications.   But Christy's story doesn't stop at survival. She shares how she transformed her adversity into advocacy, building a vibrant online community and launching her own podcast, Chronically Christy, to connect with and uplift other kidney patients.   With honesty and wisdom, Christy speaks about:

Drs Carol H. Wysham and Liana K. Billings discuss how to incorporate SGLT2 inhibitors and GLP-1 receptor agonists into the management of patients with type 2 diabetes and chronic kidney disease. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002049. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Type 2 Diabetes Mellitus https://emedicine.medscape.com/article/117853-overview Chronic Kidney Disease (CKD) https://emedicine.medscape.com/article/238798-overview Global, Regional, and National Burden of Chronic Kidney Disease Due to Diabetes Mellitus Type 2 From 1990 to 2021, With Projections to 2036: A Systematic Analysis for the Global Burden of Disease Study 2021 https://pubmed.ncbi.nlm.nih.gov/40034386/ Advantages, Limitations, and Clinical Considerations in Using Cystatin C to Estimate GFR https://pubmed.ncbi.nlm.nih.gov/36514729/ New Creatinine- and Cystatin C-Based Equations to Estimate GFR Without Race https://pubmed.ncbi.nlm.nih.gov/34554658/ Effects of Semaglutide on Chronic Kidney Disease in Patients With Type 2 Diabetes https://pubmed.ncbi.nlm.nih.gov/38785209/ Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy https://pubmed.ncbi.nlm.nih.gov/30990260/ Dapagliflozin in Patients With Chronic Kidney Disease https://pubmed.ncbi.nlm.nih.gov/32970396/ Empagliflozin in Patients With Chronic Kidney Disease https://pubmed.ncbi.nlm.nih.gov/36331190/ Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 https://pubmed.ncbi.nlm.nih.gov/39651975/ CKD Early Identification & Intervention Toolkit https://kdigo.org/wp-content/uploads/2019/01/ISN_KDIGO_EarlyScreeningBooklet_WEB_updatedOct11.pdf Combination Therapy as a New Standard of Care in Diabetic and Non-Diabetic Chronic Kidney Disease https://pubmed.ncbi.nlm.nih.gov/39907542/ Living With Chronic Kidney Disease and Type 2 Diabetes Mellitus: The Patient and Clinician Perspective https://pubmed.ncbi.nlm.nih.gov/36282450/

In this episode of Kidney Talk, Lori welcomes Dr. Richard Johnson - renowned nephrologist, author of Comprehensive Clinical Nephrology, and a pioneer in kidney disease research. Together, they dive into the fascinating connection between gut health and chronic kidney disease, exploring how good bacteria can support kidney function. Dr. Johnson shares insights on probiotics like Renadyl, leaky gut syndrome, and how gut imbalances might impact people who are on dialysis or have elevated creatinine levels. This enlightening conversation uncovers why gut health matters more than we ever imagined.

The authors evaluate the efficacy and safety of emerging therapeutic strategies for CKD management, including sodium-glucose cotransporter 2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1RA), finerenone, sacubitril/valsartan, and potassium binders. Read the full text manuscript at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70014.

Dr. Centor discusses recent Kidney Disease: Improving Global Outcomes clinical recommendations for the care of patients with chronic kidney disease.

In this podcast, Dr. Valentin Fuster reviews findings from the SUMMIT trial, which examined how tirzepatide impacts patients with obesity-related heart failure with preserved ejection fraction (HFpEF) and chronic kidney disease (CKD). The study revealed that while tirzepatide improved cardiovascular outcomes and slightly boosted kidney function, the benefits in CKD patients may stem from mechanisms beyond glomerular filtration alone.

View the Show Notes For This Episode Dr. Robin Rose discusses Kidney Care with Peptides with Dr. Ben Weitz. [If you enjoy this podcast, please give us a rating and review on Apple Podcasts, so more people will find The Rational Wellness Podcast. Also check out the video version on my WeitzChiro YouTube page.]   Podcast Highlights In this episode of the Rational Wellness Podcast, Dr. Ben Weitz hosts Dr. Robin Rose to discuss crucial insights into kidney health. They explore the kidney's functions, including filtering blood, regulating electrolytes, and converting vitamin D. The conversation delves into chronic kidney disease, highlighting that symptoms can arise even in stage two when GFR drops below 60. Dr. Rose emphasizes the importance of early detection and intervention, discussing concepts such as uremic dysbiosis, endothelial damage, leaky gut, and the impact of toxins. They also touch on natural and supplemental approaches to support kidney health, like using bio-regulator peptides, nutritional therapy, and plant-based diets. Additionally, Dr. Rose shares her personal experience with kidney cancer and the insights she gained during her journey to recovery.   00:26 Understanding Kidney Functions and Chronic Kidney Disease 02:10 In-Depth Discussion with Dr. Robin Rose 02:34 The Complexities of Kidney Health 04:28 Kidney and Gut Health Connection 04:54 Challenges in Measuring Kidney Function 08:48 Managing Kidney Health Through Diet and Lifestyle 28:43 Nutritional Supplements for Kidney Health 33:23 Butyrate and Gut Health 33:56 Cardiovascular Markers and Genomics 34:59 Kidney Health Botanicals 37:31 Peptides and Their Benefits 43:06 Bio-Regulator Peptides 51:31 Personal Kidney Health Journey 52:48 Hydration and Herbal Teas 54:40 Final Thoughts and Resources     ________________________________________________________________________________________________________ Dr. Robin Rose is a Medical Doctor and an expert at supporting kidney health using a wholistic approach and peptides.  She has recently published a book, Renology Peptides: Kidney Success with Bioregulator Peptides. Renology Peptides is a comprehensive clinical volume that presents an evidence-guided scholarly tool to deepen understanding of regenerative kidney medicine and bioregulator peptides. Her website is Renology is Kidney Success.    Dr. Ben Weitz is available for Functional Nutrition consultations specializing in Functional Gastrointestinal Disorders like IBS/SIBO and Reflux and also Cardiometabolic Risk Factors like elevated lipids, high blood sugar, and high blood pressure.  Dr. Weitz has also successfully helped many patients with managing their weight and improving their athletic performance, as well as sports chiropractic work by calling his Santa Monica office 310-395-3111.

https://www.nejm.org/doi/full/10.1056/NEJMoa2204233

This podcast will discuss an approach to pediatric chronic kidney disease. The podcast was created by Alexis Filyk, a second-year medical student at the University of Alberta, and Dr. Michelle Ruhl, a pediatric nephrologist at the Stollery Children's Hospital in Edmonton, Alberta.

Big Pharma pays billions for direct-to-consumer TV drug ads—is it time to ban them? Focused ultrasound obliterates liver tumors with minimal side effects; Nurse tricks woman into believing she's dying of cancer to cash in on her $1.5 million life insurance policy; Arizona bans insurance denial by AI automated systems; Study overturns view that very low-carb diets are bad for kidney disease patients; Strategies for reviving a lagging thyroid.

Why does a potentially deadly condition that affects 1 in 7 adults fly under the radar, undetected and undiscussed? Join us on this episode of Quality Matters as we explore Chronic Kidney Disease (CKD), a silent killer that's finally coming into the limelight of quality improvement.Our conversation begins with Dr. Ben Oldfield, a primary care physician, who sheds light on the startling prevalence and hidden complexities of CKD. Why is it so hard to detect, even with simple blood and urine tests? And why does this condition, despite its extensive impact, often get lost in the shuffle of busy health care visits?We'll unpack the challenges of diagnosing and managing CKD, exploring the emotional weight the diagnosis carries for patients and the hurdles clinicians face in communicating about it. Discover why CKD is a “loaded term” and how we can shift the narrative from fear to empowerment.But that's not all. We'll also tackle the big picture: How CKD fits into the broader landscape of cardiovascular, kidney, and metabolic (CKM) disorders. Could a holistic approach to these interconnected conditions revolutionize patient care?The conversation ends with Ben's thoughtful observations on how classic literature, particularly epic poetry, helps doctors make sense of health care's emotional complexities, connect with patients and find empowerment in the face of life and death.Join us as we explore how we can move CKD from the sidelines to the front lines of quality improvement, and how collaborative, longitudinal care can make a real difference.Key Quote:“Thinking about chronic kidney disease is a longitudinal process. It's only half the story to make the diagnosis in a snapshot in time. What's the follow up like? How are we doing with the patient over time? Because oftentimes quality measures can look at things in a snapshot in time. Chronic kidney disease really begs us to think more longitudinally.”“Benjamin Oldfield, MDTime Stamps:(02:54) The Silent Nature of CKD(07:05) Quality Measurement and CKD(11:08) The Link Between CKD and Cardiovascular Kidney Metabolic syndrome(13:06) CKD and CKM as Quality Priorities (15:45) Narrative Medicine and Personal InsightsLinks:NCQA Kidney Health ToolkitConnect with Benjamin Oldfield

The Clare branch of the Irish Kidney Assocation says it's "lobbying very hard" for a dialysis unit in Clare this World Kidney Day. In conjunction with the annual awareness day which has rolled around again, the Irish Kidney Association, or IKA, has launched its '1 in 10 People' campaign to shine a light on kidney health awareness. The campaign, according to the IKA, is intended to make people more aware of kidney-related health conditions. It's estimated that one in 10 people in Ireland and one in seven over the age of 50 are living with Chronic Kidney Disease or CKD. Of these, a startling 98% don't know they have the condition which is on track to be the fifth leading cause of death here by 2040. Clare people in need of renal care currently have to go either to University Hospital Limerick or its satellite centre on the Dock Road in Limerick. While the HSE had at one point said Ennis Hospital would have a dialysis unit by the end of this year, this has now been pushed back to November 2026. Chairperson of the Clare branch of the IKA Dermot Hayes people here are travelling an exceptional distance to access the care they need. At this week's meeting of Clare County Council, Clarecastle Sinn Féín Councillor Tommy Guilfoyle tabled a motion seeking clarity on the delivery of the Ennis dialysis unit. Specifically, he's requested a precise timeline on the commencement of services, confirmation of its location, details of the contractor and confirmation of the project's current status. He says many in this county are confused and need answers as a matter of urgency.

A new study by researchers at the University of Limerick has revealed an extraordinarily high burden of kidney disease in older individuals in Ireland that suffer from common chronic conditions. We hear from Professor Austin Stack, Senior Author on the study and Consultant Nephrologist at UL.

Dr. Kirk Welker is Dr. Hiatt's guest this month. They discuss the research and collaboration involved in creating the State of Practice: ASNR Statement on Gadolinium-Based Contrast Agent Use in Patients with Chronic Kidney Disease, published in the February issue of AJNR. Be sure to visit our website to watch the video version of this podcast. (13:04)

Send us a textIn this episode, we have Dr. Lisa Dubrofsky (Nephrology, University of Toronto) speaking about the KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.Host: Dr. Catherine Leurer (Geriatrics Fellow)Sound editing by:  Krzystof KowalikSupport the show

Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826241296668

BUFFALO, NY- January 28, 2025 – A new #research paper was #published in Volume 16, Issue 22 of Aging (Aging-US) on December 20, 2024, titled, “Impaired renal transporter gene expression and uremic toxin excretion as aging hallmarks in cats with naturally occurring chronic kidney disease.” This study, led by researchers Qinghong Li, James A. Holzwarth, Bethany Smith, Sonia Karaz, Mathieu Membrez, Vincenzo Sorrentino, Stacie Summers, Julie Spears, and Eugenia Migliavacca from Nestlé Purina Research and Oregon State University, explores how aging affects kidney function in cats with chronic kidney disease (CKD). The researchers found that older cats have lower levels of important kidney transporter genes, which usually help remove harmful waste products from the blood. These findings could help veterinarians better understand CKD in aging cats and offer insights that may be relevant to human kidney health. "Chronic kidney disease (CKD) is a naturally occurring kidney disease common in both geriatric cats and older people. Despite differing etiology, both species share many pathophysiological similarities, including chronic tubulointerstitial inflammation and fibrosis." Older cats with CKD struggle to filter toxins from their bloodstream effectively. In this study, the researchers analyzed kidney samples from two cat cohorts aged 6 to 21 years. The cohort number one included 41 colony cats: 28 control and 13 CKD cats. The cohort number two had 30 privately owned cats with 10 control and 20 CKD cats. They discovered that certain transporter genes, such as OAT1, OAT4, OATP4C1 and ABCC2, were significantly decreased in cats with CKD compared to healthy cats. The research team also found increased levels of harmful toxins in the blood of cats with CKD. Even healthy older cats had higher toxin levels compared to younger cats, showing that aging itself might contribute to declining kidney function. Monitoring kidney transporters levels and toxin buildup may help detect the disease early and improve treatment options. The researchers highlight the importance of regular veterinary check-ups to catch kidney problems early and keep cats healthier for longer. Because cats and humans share similar kidney health challenges, studying feline CKD can provide valuable insights into human kidney disease and aging. Continued research is essential to develop treatments that may improve kidney function in aging cats and potentially benefit humans as well. DOI - https://doi.org/10.18632/aging.206176 Corresponding author - Qinghong Li - qinghong.li@rd.nestle.com Video short - https://www.youtube.com/watch?v=WuEP9PXtx2A Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206176 Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts Keywords - aging, trimethylamine N-oxide, indoxyl sulfate, OAT1, OATP4C1, ABCC2 About Aging-US The mission of the journal is to understand the mechanisms surrounding aging and age-related diseases, including cancer as the main cause of death in the modern aged population. The journal aims to promote 1) treatment of age-related diseases by slowing down aging, 2) validation of anti-aging drugs by treating age-related diseases, and 3) prevention of cancer by inhibiting aging. (Cancer and COVID-19 are age-related diseases.) Please visit our website at https://www.Aging-US.com​​ and connect with us: Facebook - https://www.facebook.com/AgingUS/ X - https://twitter.com/AgingJrnl Instagram - https://www.instagram.com/agingjrnl/ YouTube - https://www.youtube.com/@AgingJournal LinkedIn - https://www.linkedin.com/company/aging/ Pinterest - https://www.pinterest.com/AgingUS/ Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

Nephrologist Manjula Tamura discusses the downsides of kidney dialysis, especially for old or frail patients. Her field has set its sights on offering alternatives, including supportive medical management without dialysis, dialysis in increments, wearable artificial kidneys, and transplanted kidneys from genetically modified pigs – in addition to advances in preventive care that can help humans avoid kidney failure in the first place. Dialysis can extend life, she says, but it is a lifestyle change. The goal is to ensure that every patient's choice aligns with their values and life goals, Tamura tells host Russ Altman in this episode of Stanford Engineering's The Future of Everything podcast.Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your quest. You can send questions to thefutureofeverything@stanford.edu.Episode Reference Links:Stanford Profile: Manjula Kurella TamuraConnect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / FacebookChapters:(00:00:00) IntroductionRuss Altman introduces guest, Manjula Tamura, a professor of medicine and nephrology at Stanford University Medical School.(00:02:58) The Kidney's Vital RoleThe kidney's role and why its failure is life-threatening.(00:04:51) Causes of Kidney FailureThe leading causes of kidney failure in developed countries.(00:07:58) Kidney TransplantationThe feasibility, barriers, and supply challenges of kidney transplantation.(00:09:50) The Dialysis ProcessHow hemodialysis and peritoneal dialysis work and patient experiences.(00:14:07) The Evolution of Dialysis TreatmentThe history of dialysis and how Medicare's expansion influenced its use.(00:18:48) Study Design: Emulating Clinical TrialsUsing VA electronic health records to simulate trials on dialysis.(00:25:31) Findings: Survival vs. Time at HomeThe trade-offs between extended survival and reduced time at home.(00:27:02) Quality of Life and DialysisMeasuring quality of life impacts through electronic health records.(00:30:32) The Future of Kidney TreatmentsInnovations like xenotransplantation and wearable artificial kidneys.(00:33:04) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook

Chronic kidney disease develops among 30% to 40% of people with type 1 or type 2 diabetes during their lifetime. Author Ian H. de Boer, MD, MS, of the University of Washington Division of Nephrology, discusses the evaluation and treatment of chronic kidney disease in patients with type 1 and type 2 diabetes with JAMA Senior Editor Karen Lasser, MD, MPH. Related Content: Diabetes and Chronic Kidney Disease

Send us a textHappy Holidays Rounds Table Listeners! For our penultimate episode of 2024, we are back with a special treat! This week, Drs. Mike and John Fralick chat about the top five RCTs published over the past year:Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (0:00 – 3:40).Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (3:40 – 9:00).Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (9:00 – 13:55).Tirzepatide for Metabolic-Dysfunction Associated Steatohepatitis with Liver Fibrosis (13:55 – 20:00).Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections (the Balance Trial) (20:00 – 23:30).And for the Good Stuff:Toronto Star Santa Claus Fund, Calgary Food Bank, Epilepsy Canada (23:30 – 24:51).Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePodsSupport the show

Happy Holidays Rounds Table Listeners! For our penultimate episode of 2024, we are back with a special treat! This week, Drs. Mike and John Fralick chat about the top five RCTs published over the past year:Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (0:00 – 3:40).Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (3:40 – 9:00).Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (9:00 – 13:55).Tirzepatide for Metabolic-Dysfunction Associated Steatohepatitis with Liver Fibrosis (13:55 – 20:00).Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections (the Balance Trial) (20:00 – 23:30).And for the Good Stuff:Toronto Star Santa Claus Fund, Calgary Food Bank, Epilepsy Canada (23:30 – 24:51).Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePods

Dr. Shika Pappoe, CMO and COO of Carna Health is working to identify and treat chronic kidney disease earlier through screening tests. This is a breakthrough for a disease that often shows no symptoms until the damage is irreversible. Using technology and AI-powered risk prediction models to improve early detection and intervention for CKD can help slow or even halt the progression of the disease. In recent pilot programs in Bermuda and Cameroon, Carna Health found high rates of CKD and is working to connect those patients with the necessary care.   Shika explains, "Chronic kidney disease is a condition that has been growing over the years. We know that diabetes and hypertension are leading causes, and currently, CKD is the 10th leading cause of death globally. And by 2040, it's estimated that it will be the fifth cause of death. Carna is working on finding ways to identify kidney disease early so that we can slow progression and optimize the outcomes of patients around the world." "We are seeing globally increasing rates of, again, diabetes and hypertension, the number one and two causes globally. Interestingly, communicable diseases have often been the priority in low- and middle-income countries. Still, we're seeing the rise of noncommunicable diseases such as CKD. I should say one of the other causes of this increasing epidemic is the environmental stressors, particularly heat. So. we see a lot of individuals who are working or living in very hot climates who are developing recurrent episodes of acute kidney injury, which ultimately leads to CKD. So, we have numerous causes for the increasing epidemic of CKD around the globe." #CarnaHealth #ChronicKidneyDisease #CKD #EarlyDetectionCKD Carna.Health Listen to the podcast here

Dr. Shika Pappoe, CMO and COO of Carna Health is working to identify and treat chronic kidney disease earlier through screening tests. This is a breakthrough for a disease that often shows no symptoms until the damage is irreversible. Using technology and AI-powered risk prediction models to improve early detection and intervention for CKD can help slow or even halt the progression of the disease. In recent pilot programs in Bermuda and Cameroon, Carna Health found high rates of CKD and is working to connect those patients with the necessary care.   Shika explains, "Chronic kidney disease is a condition that has been growing over the years. We know that diabetes and hypertension are leading causes, and currently, CKD is the 10th leading cause of death globally. And by 2040, it's estimated that it will be the fifth cause of death. Carna is working on finding ways to identify kidney disease early so that we can slow progression and optimize the outcomes of patients around the world." "We are seeing globally increasing rates of, again, diabetes and hypertension, the number one and two causes globally. Interestingly, communicable diseases have often been the priority in low- and middle-income countries. Still, we're seeing the rise of noncommunicable diseases such as CKD. I should say one of the other causes of this increasing epidemic is the environmental stressors, particularly heat. So. we see a lot of individuals who are working or living in very hot climates who are developing recurrent episodes of acute kidney injury, which ultimately leads to CKD. So, we have numerous causes for the increasing epidemic of CKD around the globe." #CarnaHealth #ChronicKidneyDisease #CKD #EarlyDetectionCKD Carna.Health Download the transcript here

Therapeutic strategies targeting the gut microbiome offer veterinarians promising interventions for managing chronic kidney disease (CKD) in cats. Tune in to this informative VetFolio Voice podcast episode to earn CE while learning about the important role of the gut-kidney axis in managing feline CKD. We address gut dysbiosis and its link to the accumulation of gut-derived uremic toxins in feline CKD patients, as well as options for caregivers that are unable to feed a renal therapeutic diet. Earn CE while learning about the importance of conducting a good history and asking open-ended questions in getting to the root cause of a behavioral issue. Want to earn CE from this episode? Be sure to log into VetFolio and take the quiz to qualify for your CE credit! https://www.vetfolio.com/courses/update-on-management-of-feline-chronic-kidney-disease-podcast-quiz

In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Dr Mark Sarnak from Tufts University in Boston. They discuss all aspects of cardiovascular risk in chronic kidney disease patients including how to mitigate the risk and future therapeutic areas. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2 or wherever you get your podcasts - it's really helpful. This podcast was funded by the Boehringer Ingelheim and Lilly Alliance. The sponsor had no influence over the podcast content, including the selection of speakers or the approval of this episode. After you've listened to the episode, test your understanding of the topic by taking the free self-assessment module hosted on BMJ Learning at https://new-learning.bmj.com/course/30000268.

Host: Darryl S. Chutka, M.D.   Guest: Aleksandra Kukla, M.D. In 2023, an estimated 14% of all adults in the U.S. or just over 35 million individuals had chronic kidney disease and it's even more common in the elderly population affecting over 1/3 of those over the age of 65. It represents the 8th leading cause of death in the U.S. It's now known that chronic kidney disease is associated with systemic inflammation, which is responsible for a variety of complications including atherosclerosis and subsequent cardiovascular disease. Does kidney disease result in inflammation or does inflammation produce renal dysfunction? Are there inflammatory markers we could measure to assess this inflammation? Can we do anything to reduce the inflammation and if so, does it improve patient outcome? These are just some of the questions I'll be asking my guest, Aleksandra Kukla, M.D., from the Division of Nephrology at the Mayo Clinic as we discuss “Chronic Kidney Disease as a Systemic Inflammatory Syndrome”. These talks on Inflammation and Cardiometabolic Disease are sponsored by Novo Nordisk Learn more about this series HERE Connect with the Mayo Clinic's School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Dr. Centor discusses reninbngiotensin system blockade in persons with advanced chronic kidney disease with Drs. Elaine Ku and Mark Sarnak.

Did you miss AHA 2024? Listen here to brief discussions of the latest research. Eric Rubin is the Editor-in-Chief of the Journal. Jane Leopold is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, J. Leopold, and S. Morrissey. NEJM at AHA — Intensive Blood-Pressure Control in Patients with Type 2 Diabetes. N Engl J Med. DOI: 10.1056/NEJMe2414476.

First, she lost her younger brother to chronic kidney disease.Then last year, Ufuoma McDermott was also diagnosed of Stage 3 kidney disease - after battling with it for 12 years. She was told to slow down at work and rest. But she thought she had more time and negotiated with her doctors. That delay turned out to be costly. She was shortly diagnosed of Stage 4 kidney disease. Stage 4. That's the final stage. And she says it was a result of drug abuse - ingesting too many painkillers. Thus began a battle for her life, where there was zero room for error. For 6 months, she couldn't move. She couldn't work. She couldn't add weight. She actually thought the end had come. In this exclusive interview, the actor and producer shares how she found her way back from Stage 4 kidney disease, how it changed how she lived her life, how she managed her public career while dealing with this in private, and why this life-changing experience has transformed the way she lives her life today. Also for the first time, she confirms that over the past few years she has lived with her family abroad while acting and producing in Nigeria - and how a very private life has served her very well. This was one hell of a conversation.  Exclusive Patron-only Content Hosted on Acast. See acast.com/privacy for more information.

In this episode, Dr. Valentin Foster explores the October issue of JACC, which highlights obesity and the potential benefits of glucagon-like peptide receptor agonists, particularly semaglutide, in treating heart failure. He delves into the FLOW trial, revealing how semaglutide significantly reduced heart failure events and cardiovascular death in patients with type 2 diabetes and chronic kidney disease, while also addressing the study's limitations and the need for improved diagnostic criteria in future research.

Send us a textIn this special episode of The Incubator podcast, Ben and Daphna wrap up the 2024 Delphi Neonatal Innovation Conference, sharing their favorite moments and highlights. This episode features the exclusive audio from four captivating Delphi talks. Dr. Suresh Gautham, Chair of Pediatrics at Nemours Children's Hospital, opens with an intriguing talk on "What Neonatologists Can Learn from Sherlock Holmes," drawing parallels between neonatal practice and detective work. Dr. Terrie Inder from CHOC delivers insights in "The Science and Art of Improving Neurological Outcomes in NICU Graduates," blending research with practical care strategies. Pediatric nephrologist Chryso Pefkaros Katsoufis from the University of Miami explores "The Road Less Traveled? Neonatal Biomarkers of Chronic Kidney Disease," shedding light on innovative approaches to CKD in newborns. Finally, Dr. Lauren Ruoss, from Winnie Palmer Hospital, enchants the audience with "Abracadabra! Making POCUS Appear in the NICU," detailing the role of point-of-care ultrasound in neonatal care. Ben and Daphna conclude the episode by previewing exciting upcoming developments for The Incubator network. Don't miss this unique opportunity to hear from some of the leading voices in neonatal care.As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textIn this special episode of The Incubator podcast, Ben and Daphna wrap up the 2024 Delphi Neonatal Innovation Conference, sharing their favorite moments and highlights. This episode features the exclusive audio from four captivating Delphi talks. Dr. Suresh Gautham, Chair of Pediatrics at Nemours Children's Hospital, opens with an intriguing talk on "What Neonatologists Can Learn from Sherlock Holmes," drawing parallels between neonatal practice and detective work. Dr. Terrie Inder from CHOC delivers insights in "The Science and Art of Improving Neurological Outcomes in NICU Graduates," blending research with practical care strategies. Pediatric nephrologist Chryso Pefkaros Katsoufis from the University of Miami explores "The Road Less Traveled? Neonatal Biomarkers of Chronic Kidney Disease," shedding light on innovative approaches to CKD in newborns. Finally, Dr. Lauren Ruoss, from Winnie Palmer Hospital, enchants the audience with "Abracadabra! Making POCUS Appear in the NICU," detailing the role of point-of-care ultrasound in neonatal care. Ben and Daphna conclude the episode by previewing exciting upcoming developments for The Incubator network. Don't miss this unique opportunity to hear from some of the leading voices in neonatal care.As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textIn this special episode of The Incubator podcast, Ben and Daphna wrap up the 2024 Delphi Neonatal Innovation Conference, sharing their favorite moments and highlights. This episode features the exclusive audio from four captivating Delphi talks. Dr. Suresh Gautham, Chair of Pediatrics at Nemours Children's Hospital, opens with an intriguing talk on "What Neonatologists Can Learn from Sherlock Holmes," drawing parallels between neonatal practice and detective work. Dr. Terrie Inder from CHOC delivers insights in "The Science and Art of Improving Neurological Outcomes in NICU Graduates," blending research with practical care strategies. Pediatric nephrologist Chryso Pefkaros Katsoufis from the University of Miami explores "The Road Less Traveled? Neonatal Biomarkers of Chronic Kidney Disease," shedding light on innovative approaches to CKD in newborns. Finally, Dr. Lauren Ruoss, from Winnie Palmer Hospital, enchants the audience with "Abracadabra! Making POCUS Appear in the NICU," detailing the role of point-of-care ultrasound in neonatal care. Ben and Daphna conclude the episode by previewing exciting upcoming developments for The Incubator network. Don't miss this unique opportunity to hear from some of the leading voices in neonatal care. As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textIn this special episode of The Incubator podcast, Ben and Daphna wrap up the 2024 Delphi Neonatal Innovation Conference, sharing their favorite moments and highlights. This episode features the exclusive audio from four captivating Delphi talks. Dr. Suresh Gautham, Chair of Pediatrics at Nemours Children's Hospital, opens with an intriguing talk on "What Neonatologists Can Learn from Sherlock Holmes," drawing parallels between neonatal practice and detective work. Dr. Terrie Inder from CHOC delivers insights in "The Science and Art of Improving Neurological Outcomes in NICU Graduates," blending research with practical care strategies. Pediatric nephrologist Chryso Pefkaros Katsoufis from the University of Miami explores "The Road Less Traveled? Neonatal Biomarkers of Chronic Kidney Disease," shedding light on innovative approaches to CKD in newborns. Finally, Dr. Lauren Ruoss, from Winnie Palmer Hospital, enchants the audience with "Abracadabra! Making POCUS Appear in the NICU," detailing the role of point-of-care ultrasound in neonatal care. Ben and Daphna conclude the episode by previewing exciting upcoming developments for The Incubator network. Don't miss this unique opportunity to hear from some of the leading voices in neonatal care.As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textIn this special episode of The Incubator podcast, Ben and Daphna wrap up the 2024 Delphi Neonatal Innovation Conference, sharing their favorite moments and highlights. This episode features the exclusive audio from four captivating Delphi talks. Dr. Suresh Gautham, Chair of Pediatrics at Nemours Children's Hospital, opens with an intriguing talk on "What Neonatologists Can Learn from Sherlock Holmes," drawing parallels between neonatal practice and detective work. Dr. Terrie Inder from CHOC delivers insights in "The Science and Art of Improving Neurological Outcomes in NICU Graduates," blending research with practical care strategies. Pediatric nephrologist Chryso Pefkaros Katsoufis from the University of Miami explores "The Road Less Traveled? Neonatal Biomarkers of Chronic Kidney Disease," shedding light on innovative approaches to CKD in newborns. Finally, Dr. Lauren Ruoss, from Winnie Palmer Hospital, enchants the audience with "Abracadabra! Making POCUS Appear in the NICU," detailing the role of point-of-care ultrasound in neonatal care. Ben and Daphna conclude the episode by previewing exciting upcoming developments for The Incubator network. Don't miss this unique opportunity to hear from some of the leading voices in neonatal care.As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Today, Fei and Nick discuss chronic kidney disease and pregnancy. What do we need to know about CKD, and how does it affect pregnancy outcomes?  A new exciting announcement: we have started OB/Gyn GOALS, located at obgyngoals.org. This is a free, weekly residency curriculum focused on CREOG learning objectives. Sign up now to receive your weekly lesson!  Twitter: @creogsovercoff1 Instagram: @creogsovercoffee Facebook: www.facebook.com/creogsovercoffee Website: www.creogsovercoffee.com Patreon: www.patreon.com/creogsovercoffee You can find the OBG Project at: www.obgproject.com